We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $1.16B
1-Year Est. Return 36.23%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+36.23%
3 Year Est. Return
+108.69%
5 Year Est. Return
+124.54%
10 Year Est. Return
+352.99%
AUM
$754M
AUM Growth
-$5.17B
Cap. Flow
-$747M
Cap. Flow %
-99.03%
Top 10 Hldgs %
14.17%
Holding
3,525
New
757
Increased
256
Reduced
520
Closed
1,975

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$31.9M
2
AAPL icon
Apple
AAPL
+$30.9M
3
MSFT icon
Microsoft
MSFT
+$25.9M
4
NKE icon
Nike
NKE
+$24M
5
NVDA icon
NVIDIA
NVDA
+$20.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.2%
2 Technology 9.83%
3 Consumer Discretionary 8.98%
4 Financials 6.13%
5 Industrials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1376
DELISTED
Allakos
ALLK
$14.3K ﹤0.01%
+11,787
New +$12.4K
BPTH
1377
DELISTED
Bio-Path Holdings Inc
BPTH
$14.2K ﹤0.01%
+12,237
New +$11.4K
AIM
1378
AIM ImmunoTech
AIM
$8.13M
$14.1K ﹤0.01%
+714
New +$16.6K
LNAI
1379
Lunai Bioworks
LNAI
$10.6M
$14.1K ﹤0.01%
+211
New +$14K
IPW icon
1380
iPower
IPW
$1.62M
$14K ﹤0.01%
+8
New +$20.8K
INDP icon
1381
Indaptus Therapeutics
INDP
$473M
$14K ﹤0.01%
+594
New +$18.9K
SAIH
1382
SAIHEAT Ltd
SAIH
$47.4M
$13.9K ﹤0.01%
1,206
-938
-44% -$12.9K
JOB icon
1383
GEE Group
JOB
$25.8M
$13.9K ﹤0.01%
67,077
+47,145
+237% +$11.7K
KRON
1384
DELISTED
Kronos Bio
KRON
$13.8K ﹤0.01%
14,532
+3,410
+31% +$3.22K
KLRS
1385
Kalaris Therapeutics
KLRS
$76.2M
$13.7K ﹤0.01%
+1,416
New +$21.4K
PGEN icon
1386
Precigen
PGEN
$2.79B
$13.6K ﹤0.01%
+12,173
New +$10.4K
SENS icon
1387
Senseonics Holdings Inc
SENS
$507M
$13.6K ﹤0.01%
+1,300
New +$9.29K
THCH icon
1388
TH International
THCH
$43.2M
$13.5K ﹤0.01%
3,798
-4,004
-51% -$15.2K
REVB icon
1389
Revelation Biosciences
REVB
$3.71M
$13.4K ﹤0.01%
+152
New +$20.3K
VANI icon
1390
Vivani Medical
VANI
$107M
$13.3K ﹤0.01%
11,503
-44,622
-80% -$56.5K
DLPN icon
1391
Dolphin Entertainment
DLPN
$14.3M
$13.3K ﹤0.01%
+12,456
New +$15K
AEON icon
1392
AEON Biopharma
AEON
$12.1M
$13.2K ﹤0.01%
+341
New +$19.9K
WRN
1393
Western Copper and Gold
WRN
$547M
$13.2K ﹤0.01%
+12,538
New +$14.3K
GRI
1394
GRI Bio
GRI
$4.22M
$13.1K ﹤0.01%
+33
New +$11.3K
BIAF icon
1395
bioAffinity Technologies
BIAF
$5.66M
$13.1K ﹤0.01%
+32
New +$19.3K
FTFT icon
1396
Future FinTech Group
FTFT
$44.4M
$13.1K ﹤0.01%
66
+43
+187% +$9.62K
SPI
1397
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$13K ﹤0.01%
33,775
+18,817
+126% +$7.63K
BNKK
1398
Bonk Inc
BNKK
$10.8M
$12.9K ﹤0.01%
513
-37
-7% -$1.27K
ANGH icon
1399
Anghami
ANGH
$33.1M
$12.9K ﹤0.01%
+1,560
New +$12.2K
ESLA icon
1400
Estrella Immunopharma
ESLA
$23M
$12.8K ﹤0.01%
+10,640
New +$10.7K

Similar funds

Two Sigma Securities's Q4 2024 Portfolio in Review

As of Q4 2024, Two Sigma Securities held 3,525 positions worth $754M, down 87% from $5.92B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Securities withdrew a net $747M in Q4 2024, closing 1,975 positions and reducing 520 holdings. Its most notable exit was Nike, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 83% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Two Sigma Securities opened a new position in iShares Core S&P 500 ETF worth $8.32M.

  • Two Sigma Securities's largest Q4 2024 buy was iShares Core S&P 500 ETF: 14,140 shares worth $8.32M.
  • Two Sigma Securities added most to iShares 20+ Year Treasury Bond ETF in Q4 2024, an estimated $6.57M increase.
  • Two Sigma Securities's biggest Q4 2024 reduction was Tesla, cutting an estimated $31.9M.
  • Two Sigma Securities fully exited Nike in Q4 2024, selling an estimated $24M.
  • Two Sigma Securities's ten largest holdings make up 14% of its $754M portfolio in Q4 2024.
  • Two Sigma Securities opened 757 new positions and closed 1,975 in Q4 2024.
  • Two Sigma Securities's portfolio value fell 87% quarter-over-quarter to $754M.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.